18 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
withheld material information from the USPTO, or the applicable foreign counterpart, or made a misleading statement, during prosecution. A litigant
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
withheld material information from the USPTO, or the applicable foreign counterpart, or made a misleading statement, during prosecution. A litigant
6-K
EX-99.3
XRTX
XORTX Therapeutics Inc
3 Apr 23
Consolidated Financial Statements
6:05am
, during prosecution. A litigant or the USPTO itself could challenge our patents on this basis even if we believe that we have conducted our patent
424B4
fsdxggirz1t7b7u sobg
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
peqx80bk6rat5108tpsk
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
g53w045qfskczhj
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1
w38j4u57 tb2n
8 Sep 22
Registration statement (foreign)
1:02pm
DRS
zna1k0
15 Aug 22
Draft registration statement
12:00am
20-F
sxp4ktnsc
3 May 22
Annual report (foreign)
5:29pm
6-K
EX-99.1
vbcol
13 Apr 22
Current report (foreign)
7:23am
424B4
u0nw5 0atq
14 Oct 21
Prospectus supplement with pricing info
4:30pm
F-1/A
e39i5ij1 29k
4 Oct 21
Registration statement (foreign) (amended)
12:00am
F-1/A
ro7010x8w 96dqgf0h
16 Sep 21
Registration statement (foreign) (amended)
5:16pm
F-1
k8mx3
11 Aug 21
Registration statement (foreign)
9:55pm
DRS/A
tm6ib7djy33
21 Jul 21
Draft registration statement (amended)
12:00am
DRS
jgvyx82ip
26 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next